Summary

The global biological safety testing market size was valued at USD 4.95 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 13.29 Billion by 2033, exhibiting a CAGR of 10.38% during 2025-2033. North America currently dominates the market, holding a significant market share of over 38.8% in 2024. The expansion of the pharmaceutical and biotechnology sectors, the impact of the COVID-19 pandemic, and the rising emphasis on regulatory compliance and safety standards are some of the major factors increasing the biological safety testing market share.

The increasing demand for biopharmaceuticals, vaccines, and biosimilars drives the biological safety testing market due to rising healthcare needs and chronic disease prevalence. Stringent regulatory guidelines for product safety and efficacy, and the growing investment in biotechnology research and development, further fuel market growth. Advancements in cell and gene therapies and the expansion of contract research organizations (CROs) have also boosted the demand for reliable safety testing. The rise in infectious diseases and pandemic preparedness has accelerated vaccine production, necessitating rigorous safety testing. Innovations in testing technologies, such as automated systems and high-throughput screening, enhance testing efficiency, contributing to the market's expansion. The increasing awareness about product quality further drives the biological safety testing market growth across the globe.

The biological safety testing market in the United States is driven by the growing demand for biopharmaceuticals, vaccines, and advanced therapies due to the rising prevalence of chronic and infectious diseases. Stringent regulatory standards from the FDA and other authorities necessitate comprehensive safety testing to ensure product quality and compliance. The U.S. is also a leader in adopting innovative testing technologies, including automation and high-throughput systems, enhancing testing accuracy and efficiency. Additionally, the presence of well-established pharmaceutical companies, a strong focus on pandemic preparedness, and the growth of contract research organizations (CROs) represent some of the key biological safety testing market trends. For instance, in October 2024, in Rockville, Maryland, USA, MilliporeSigma, the Life Science division of Merck KGaA, Darmstadt, Germany, unveiled a new biosafety testing facility worth ?290 million. For conventional and innovative modalities, biosafety testing and analytical development are essential elements of medication development and commercialization. The demand for these services is increasing at a double-digit rate on a global scale. The company will be able to drive automation and technological development in a single integrated hub due to this expansion, which represents the largest investment in contract testing in its history.

Biological Safety Testing Market Trends:
Expanding Pharmaceutical and Biotechnology Sectors
The pharmaceutical and biotechnology industries are expanding due to increased investments in research and development. According to an industrial report, in 2023, global R&D spending in the pharmaceutical sector exceeded approximately USD 300 billion. The development of medications, biologics, and vaccines for a range of medical conditions, including complicated illnesses, is dominated by these sectors. As a result, there is a greater need for thorough safety evaluations, and biological safety testing is essential to guaranteeing patient safety. It entails comprehensive assessments for pollutants including bacteria, viruses, and endotoxins, ensuring adherence to safety and legal requirements. Concurrently, the evolving nature of diseases and the continuous innovation in products maintain a high demand for safety testing, including specialized assessments for emerging therapies including gene and cell therapies, contributing significantly to the biological safety testing market demand.
Impact of the COVID-19 Pandemic
The COVID-19 pandemic has significantly impacted the industry by accelerating the development and deployment of vaccines and treatments. For instance, according to the World Health Organization (WHO), more than 13 billion COVID-19 vaccine doses were administered globally by 2021. This has emphasized the crucial role of rigorous safety testing. In addition to this, governments and regulatory authorities globally have intensified their scrutiny of these products, leading to a surge in demand for various testing services, including vaccine safety assessments, virus detection assays, and quality control measures for COVID-19 diagnostics and treatments. In addition, the pandemic has changed the industry's emphasis by emphasizing the necessity of readiness for upcoming health emergencies, which has maintained market expansion.
Rising Emphasis on Regulatory Compliance
Global regulatory bodies are tightening oversight of biopharmaceutical products, emphasizing patient safety and product quality. These regulations mandate comprehensive safety evaluations, making biological safety testing integral to drug approvals. Advanced therapy medicinal products, such as gene and cell therapies, have been receiving more approvals over the past few years. For example, the Committee for Advanced Therapies of the European Medicines Agency adopted a positive draft opinion for Durveqtix (fidanacogene elaparvovec) during its plenary meeting in May 2024 for the treatment of severe and moderately severe haemophilia B. This is part of a general trend where the number of approved ATMPs is constantly on the rise. The need for testing services is increased and the significance of biological safety testing in compliance is emphasized by the strict adherence to changing standards that pharmaceutical and biotech businesses must follow to obtain product approval and market access. Additionally, the necessity for specialist testing is highlighted by the growing complexity of regulatory regulations, particularly for sophisticated therapeutics like gene and cell therapies. As specialist evaluations adjust to the distinct features of these treatments, guaranteeing their efficacy and safety while satisfying changing regulatory requirements, this maintains market growth.
Biological Safety Testing Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market report, along with forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on product and services, test type, and application.
Analysis by Product and Services:
? Kits and Reagents
? Instruments
? Services
Kits and reagents leads the market with around 41.3% of market share in 2024. The increasing trend towards decentralized testing and point-of-care (POC) diagnostics driving the need for user-friendly and portable testing kits represents one of the prime factors fueling the demand for biological safety testing. These kits enable healthcare professionals to perform safety assessments quickly and efficiently, especially in resource-limited settings. In confluence with this, the expansion of research and development activities in the life sciences, including genomics, proteomics, and cell culture, necessitates a continuous supply of high-quality testing reagents and kits for various applications, spurring market growth. Furthermore, the growing focus on ensuring product quality and safety in the food and beverage (F&B) industry, where biological contaminants can pose significant risks, is boosting demand for testing kits and reagents for microbiological analysis, aiding market expansion.
Analysis by Test Type:
? Endotoxin Tests
? Sterility Tests
? Cell Line Authentication and Characterization Tests
? Bioburden Tests
? Residual Host Contaminant Detection Tests
? Adventitious Agent Detection Tests
? Others
Endotoxin tests leads the market with around 24.9% of market share in 2024. The rising demand for endotoxin tests primarily propelled by the critical need to ensure the safety and efficacy of medical devices and pharmaceutical products is strengthening the global biological safety testing market. Endotoxins, toxic substances present in the cell walls of Gram-negative bacteria, can lead to severe health complications when introduced into the human body. The increasing complexity and diversity of medical devices, including implants and drug delivery systems, necessitate stringent testing for endotoxins to mitigate potential patient risk. Furthermore, the rising focus on personalized medicine and biopharmaceuticals, such as gene therapies and monoclonal antibodies, requires meticulous endotoxin testing to guarantee the purity and safety of these advanced therapies, strengthening the market. Besides this, regulatory agencies worldwide mandate compliance with strict endotoxin limits, reinforcing the demand for accurate and reliable endotoxin tests in pharmaceutical manufacturing and healthcare settings, thereby bolstering the market growth.
Analysis by Application:
? Vaccine Development
? Blood Products Testing
? Cellular and Gene Therapy
? Tissue and Tissue-related Products Testing
? Stem Cell Research
Vaccine development leads the market with around 28.7% of market share in 2024. The demand for biological safety testing in vaccine development is primarily propelled by the urgent global need for safe and effective vaccines. As the world faces various infectious diseases and viral outbreaks, including the COVID-19 pandemic, there is an unprecedented focus on vaccine development. Regulatory authorities require comprehensive safety assessments to ensure that vaccines are not only effective but also free from harmful contaminants. Biological safety testing plays a critical role in this process, involving the evaluation of vaccine candidates for potential viral and microbial contaminants, ensuring the absence of endotoxins, and assessing their overall safety for human use. Moreover, the emergence of novel vaccine technologies, such as mRNA-based vaccines, necessitates specialized safety evaluations, contributing to the growing demand for biological safety testing services. This heightened emphasis on vaccine safety underscores the crucial role played by such testing in safeguarding public health on a global scale.
Regional Analysis
? North America
o United States
o Canada
? Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
? Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
? Latin America
o Brazil
o Mexico
o Others
? Middle East and Africa
In 2024, North America accounted for the largest market share of over 38.8%. North America boasts a robust pharmaceutical and biotechnology industry, with a strong emphasis on research and development. The constant innovation and introduction of new drugs, biologics, and medical devices necessitate rigorous safety evaluations, driving the demand for biological safety testing services. In addition to this, the region's proactive regulatory environment, governed by stringent standards set by the FDA and other regulatory bodies, mandates comprehensive safety assessments, further propelling market growth. Moreover, the ongoing efforts to combat public health threats, such as the COVID-19 pandemic, have heightened the demand for vaccine development and testing, particularly in North America, where numerous pharmaceutical companies and research institutions are actively involved in vaccine research and production. These factors, combined with the region's advanced healthcare infrastructure and the increasing awareness of product quality and safety, continue to fuel the expansion of the North America biological safety testing market.
Key Regional Takeaways:

United States Biological Safety Testing Market Analysis
In 2024, the United States accounted for the largest market share of over 88.60% in North America. There are increased growth aspects related to U.S. biological safety testing with an increase in the development of pharmaceuticals, the rise of treatments based on biologics. In 2023 alone, the FDA approved 25 biologics under 55 newly approved drugs; 12 monoclonal antibodies (mAbs) and 5 of those were either an enzyme or protein. According to an industrial report, as of January 2024, there were 20,465 clinical trials accepting patients in the United States that clinically signified the growing need for biologics safety testing. There are major vendors of companies such as Charles River Laboratories and WuXi AppTec, which are interested in bringing testing technologies forward. The high urge for advanced safety testing of gene therapies and vaccines further amplified the market growth. The increasing focus on in-vitro testing and automation is also augmenting enhanced market efficiency. Improvements in technology are enhancing testing accuracy and reducing the turnaround time, while higher standards of safety regulatory requirements continue to drive innovation that positions the United States as the key player globally in the field of biological safety testing.
Europe Biological Safety Testing Market Analysis
The biological safety testing market is also growing in Europe due to strong regulatory framework and increased demands for safe pharmaceutical and biologic products. A recent industrial report suggests that revenue in the European pharmaceutical industry already surpassed EUR 300 billion (USD 309 billion) in 2022, which creates high demand for solutions in terms of safety testing. Germany and Switzerland happen to be strong market contributors while the pharmaceutical leaders Roche and Bayer are always concerned about their biologic safety. In more detail, especially, regulatory institutions such as EMA have upgraded testing standards due to which more quality biologic testing services flourished. Growth in the demand for clinical research, gene therapy, and also the increasing significance of biosimilars fuels the market demand. Additionally, the emerging concept of personalized medicine, coupled with precision testing, is further changing the playing field for regional safety testing service providers. Efficiency in testing has been improved with the increasing utilization of automation and AI technology.
Asia Pacific Biological Safety Testing Market Analysis
Asia Pacific's market for biological safety testing is fast growing due to increased investments in biotechnology as well as increasing pharmaceutical manufacturing. According to industrial reports, China's pharmaceutical market reached a value of USD 160 billion in 2023, which also led to greater demand for biologics. Rising population with above the age bracket population makes investment by the nation, in region attractive to multinationals for example Labcorp and Bio-merieux extending the presence based on rising spending in R and D. Advanced technologies like high-throughput testing and next-generation sequencing have been adopted by the biotech sector in the region, leading to a more sophisticated safety testing environment. In addition, strong manufacturing capabilities in the region along with cost-effective testing solutions have made it an important player in the global biological safety testing arena.
Latin America Biological Safety Testing Market Analysis
The biological safety testing market in Latin America is also on the rise, that is driven by growing pharmaceutical production and a deepening focus on compliance with international standards for safety. Brazil leads this boom, and the growing demand for biologic safety testing services can be tracked in response to the country's further increasing biologics production capability. Argentina and Mexico are also contributing to the growth through investments in upgrading their pharmaceutical manufacturing capabilities. According to an industry report, as of April 2024, Brazil boasts the highest number of clinical trials in the region with approximately 10,000 studies. Mexico ranks next with about 5,000 studies. Thus, this signifies a heavy reliance on clinical research and biologic safety. Testing requirements have become even more rigorous on the part of Brazil's regulatory body, ANVISA. This is leading to increased demands for high-tech safety testing to meet the new international standards set. Moreover, the investment by local manufacturers in testing services and infrastructure enhancement to meet the increasing demands is directly contributing to the expanding market and makes the region increasingly significant in the global biological safety testing market.
Middle East and Africa Biological Safety Testing Market Analysis
In the Middle East and Africa, the biological safety testing market is burgeoning, driven by increased healthcare investment and pharmaceutical production in many countries. Saudi Arabia's defense spending, which includes allocations for medical and pharmaceutical safety, fuels the growth of the market. The pharmaceutical market in the UAE remains in growth mode, and biological safety testing is fast becoming a key area of focus. South Africa is emerging as one of the key biomanufacturing hubs. There is a huge growth in domestic biologic production. There are 4,593 clinical trials in the Middle East and 861 in Africa as of 2022 according to the WHO International Clinical Trial Registry Platform, where there is increased demand for clinical research and biologic safety. Demand for biological safety testing services will be raised due to increases in healthcare facilities and clinical trials in the region. Testing service will grow annually at 10% over the next five years. This trend is further supported by the efforts of local governments to improve healthcare standards and infrastructure.

Competitive Landscape:
The fierce competition among major companies in the global biological safety testing market is a result of the sector's vital role in guaranteeing the quality and safety of pharmaceuticals, biologics, and medical devices. Prominent companies in this landscape engage in various strategies to maintain their market positions, such as mergers, acquisitions, and collaborations to expand their service portfolios and geographic reach. Furthermore, companies can also remain ahead of industry trends by investing in research and development to adopt cutting-edge testing technologies and procedures. The increasing focus on personalized medicine and advanced therapies, such as gene and cell therapies, presents growth opportunities for firms specializing in specialized safety testing services. Overall, the competitive landscape of the global biological safety testing market is marked by a dynamic interplay of established players.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
? Avance Biosciences
? Charles River Laboratories
? Creative Biogene
? Eurofins Scientific
? Lonza Group AG
? Maravai LifeSciences
? Pace Analytical Services Inc.
? Pacific BioLabs
? Sartorius AG
? SGS SA
? ViruSure GmbH (Asahi Kasei Corporation)
? WuXi Biologics

Key Questions Answered in This Report
1.How big is the biological safety testing market?
2.What is the future outlook of biological safety testing market?
3.What are the key factors driving the biological safety testing market?
4.Which region accounts for the largest biological safety testing market share?
5.Which are the leading companies in the global biological safety testing market?

ページTOPに戻る

Table of Contents

?1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biological Safety Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product and Services
6.1 Kits and Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Test Type
7.1 Endotoxin Tests
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Sterility Tests
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cell Line Authentication and Characterization Tests
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Bioburden Tests
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Residual Host Contaminant Detection Tests
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Adventitious Agent Detection Tests
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by Application
8.1 Vaccine Development
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Blood Products Testing
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Cellular and Gene Therapy
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Tissue and Tissue-related Products Testing
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Stem Cell Research
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Avance Biosciences
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 SWOT Analysis
14.3.2 Charles River Laboratories
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.3 Creative Biogene
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.4 Eurofins Scientific
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Lonza Group AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.6 Maravai LifeSciences
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.7 Pace Analytical Services Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Pacific BioLabs
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.9 Sartorius AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 SWOT Analysis
14.3.10 SGS SA
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 SWOT Analysis
14.3.11 ViruSure GmbH (Asahi Kasei Corporation)
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 SWOT Analysis
14.3.12 WuXi Biologics
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 SWOT Analysis

ページTOPに戻る

List of Tables/Graphs

List of Figures

Figure 1: Global: Biological Safety Testing Market: Major Drivers and Challenges
Figure 2: Global: Biological Safety Testing Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Biological Safety Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Biological Safety Testing Market: Breakup by Product and Services (in %), 2024
Figure 5: Global: Biological Safety Testing Market: Breakup by Test Type (in %), 2024
Figure 6: Global: Biological Safety Testing Market: Breakup by Application (in %), 2024
Figure 7: Global: Biological Safety Testing Market: Breakup by Region (in %), 2024
Figure 8: Global: Biological Safety Testing (Kits and Reagents) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Biological Safety Testing (Kits and Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Biological Safety Testing (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Biological Safety Testing (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Biological Safety Testing (Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Biological Safety Testing (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Biological Safety Testing (Endotoxin Tests) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Biological Safety Testing (Endotoxin Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Biological Safety Testing (Sterility Tests) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Biological Safety Testing (Sterility Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Biological Safety Testing (Cell Line Authentication and Characterization Tests) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Biological Safety Testing (Cell Line Authentication and Characterization Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Biological Safety Testing (Bioburden Tests) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Biological Safety Testing (Bioburden Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Biological Safety Testing (Residual Host Contaminant Detection Tests) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Biological Safety Testing (Residual Host Contaminant Detection Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Biological Safety Testing (Adventitious Agent Detection Tests) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Biological Safety Testing (Adventitious Agent Detection Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Biological Safety Testing (Other Test Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Biological Safety Testing (Other Test Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Biological Safety Testing (Vaccine Development) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Biological Safety Testing (Vaccine Development) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Biological Safety Testing (Blood Products Testing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Biological Safety Testing (Blood Products Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Biological Safety Testing (Cellular and Gene Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Biological Safety Testing (Cellular and Gene Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Biological Safety Testing (Tissue and Tissue-related Products Testing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Biological Safety Testing (Tissue and Tissue-related Products Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Biological Safety Testing (Stem Cell Research) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Biological Safety Testing (Stem Cell Research) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: North America: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: North America: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: United States: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: United States: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Canada: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Canada: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Asia-Pacific: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Asia-Pacific: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: China: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: China: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Japan: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Japan: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: India: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: India: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: South Korea: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: South Korea: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Australia: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Australia: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Indonesia: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Indonesia: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Others: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Others: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Europe: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Europe: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Germany: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Germany: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: France: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: France: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: United Kingdom: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: United Kingdom: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Italy: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Italy: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Spain: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Spain: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Russia: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Russia: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Others: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Others: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Latin America: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Latin America: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Brazil: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Brazil: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Mexico: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Mexico: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Others: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Others: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Middle East and Africa: Biological Safety Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: Middle East and Africa: Biological Safety Testing Market: Breakup by Country (in %), 2024
Figure 86: Middle East and Africa: Biological Safety Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Global: Biological Safety Testing Industry: SWOT Analysis
Figure 88: Global: Biological Safety Testing Industry: Value Chain Analysis
Figure 89: Global: Biological Safety Testing Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Biological Safety Testing Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Biological Safety Testing Market Forecast: Breakup by Product and Services (in Million USD), 2025-2033
Table 3: Global: Biological Safety Testing Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
Table 4: Global: Biological Safety Testing Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Biological Safety Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Biological Safety Testing Market: Competitive Structure
Table 7: Global: Biological Safety Testing Market: Key Players